We are live on ! Find out more
TMCI icon

Treace Medical Concepts

123 hedge funds and large institutions have $514M invested in Treace Medical Concepts in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 29 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $800K

117% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 29

0.19% more ownership

Funds ownership: 63.49%63.68% (+0.19%)

10% less funds holding

Funds holding: 137123 (-14)

37% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 38

48% less capital invested

Capital invested by funds: $996M → $514M (-$482M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
123
Holders Change
-14
Holders Change %
-10.22%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
24
Increased
63
Reduced
29
Closed
38
Calls
$1.76M
Puts
$800K
Net Calls
+$964K
Net Calls Change
-$1.55M

TMCI Hedge Fund Activity: Q3 2023 in Review

123 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2023, worth a combined $514M — down 48% from $996M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of TMCI and 24 opened new positions — a net loss of 14 holders — while 29 trimmed existing stakes and 63 added.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $34.9M. The largest seller was Next Century Growth Investors, cutting an estimated $19.6M.

  • 123 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2023, down from 137 in Q2 2023.
  • Funds reported $514M of Treace Medical Concepts stock for Q3 2023, down 48% quarter-over-quarter.
  • 24 funds opened new Treace Medical Concepts positions in Q3 2023 and 38 closed out, a net change of -14 holders.
  • The largest Treace Medical Concepts buyer in Q3 2023 was Soleus Capital Management, an estimated $34.9M added.
  • The largest Treace Medical Concepts seller in Q3 2023 was Next Century Growth Investors, an estimated $19.6M sold.

Based on aggregated 13F filings for Q3 2023.